UnitedHealthcare Announced It Would Cover Certain Pharmacogenomic Tests; However, Experts Hotly Debate the Value of Such Clinical Laboratory Testing

Though more payers are covering laboratory-developed genetic tests for conditions such as depression, the tests remain uncleared by the FDA Clinical pathologists interested in pharmacogenetics tests for depression and other psychiatric disorders may be interested to learn that UnitedHealthcare (NYSE:UNH) announced in its Network Bulletin a change to its Molecular Pathology Policy and is now covering certain molecular diagnostics. That’s despite the federal Food and Drug Administration (FDA)...

FDA Authorizes 23andMe to Report Results of Direct-to-Consumer Pharmacogenetics Test to Customers without a Prescription, Bypassing Doctors and Clinical Laboratories

FDA cautions patients to not use data gained from the DTC test to make healthcare decisions on their own Clinical laboratories continue to be impacted by the growing direct-to-consumer (DTC) testing market, as more walk-in lab customers order at-home tests. Now, the US Food and Drug Administration (FDA) has authorized a DTC test company to provide results of a pharmacogenetic (PGx) test to customers without needing a doctor’s order. This is the first genetic test of its kind to receive such...

MEDACorp Survey of Hospital Administrators Shows Inpatient Care is Decreasing; Could Change From Where Clinical Laboratories Receive Orders

As inpatient care declines, outpatient care expands, signaling a shift from where physician orders for medical laboratory tests originate It’s a well-established fact that the year-over-year increase in the volume of outpatient procedures is consistently greater than 8%, while the annual growth in inpatient admissions is at or below 3%. Clinical laboratory managers and anatomic pathologists are aware of these facts. MEDACorp, a strategic knowledge resource and subsidiary of Leerink Partners, a...

Press Release: Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.

A Lab Leader’s Guide To Pharmacogenomic Testing (PGx)

The Dark Report is pleased to offer this FREE White Paper, providing an enlightening overview of pharmacogenomic testing and how PGx fits into current healthcare goals, a discussion of the obstacles healthcare providers, institutions and clinical diagnostic laboratories face in entering the pharmacogenomic testing market, and examples of how a cloud-based, Software-as-a-Service platform can help healthcare providers overcome those obstacles.